Hera BioLabs In Genetic Engineering News
Hera BioLabs and our VP of Research and Development Tseten [...]
Advancements In Stem Cell-Based Therapies For Malignant Brain Tumors
Despite many great developments in the overall treatment of cancers, [...]
Hera BioLabs Receives PHS Approved Animal Welfare Assurance
Hera BioLabs, Inc. (Lexington KY) announced today that it has [...]
New Transgenic Rat Models Offer Superior Representation Of Human Cancers
Until recently, there has been a void in animal models [...]
Could Xenograft Rats Be The Future of Leukemia Research?
Chronic lymphocytic leukemia (CLL) is a relatively rare cancer, but [...]
Lexington Based Toxicology Lab, Hera BioLabs, Partners With The NIH To Use Firefly Proteins For Drug Discovery Research
Hera BioLabs, a Lexington based contract research organization (CRO), announced [...]
Solutions & Services
The quality of pre-clinical translational research often hinges on assay validation and in vitro and in vivo predictive modeling. Hera BioLabs is creating specifically engineered cell and animal models which offer robust and relevant assay platforms for efficacy and toxicity studies.